About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Development of Biofilms in CF Associated Chronic-pneumonia

by Anjali Aryamvally on October 10, 2017 at 3:35 PM
Development of Biofilms in CF Associated Chronic-pneumonia

Individuals with cystic fibrosis (CF), have an increased risk of developing chronic pneumonia. The characteristic thick and sticky mucus in the lungs of a CF affected person is an ideal environment for the growth of pneumonia causing bacteria. Once chronic pneumonia develops, cure is not an option and can become fatal. The most common bacterium responsible for chronic pneumonia in CF patients is P. aeruginosa.

In a study published in the Journal of Bacteriology, Indiana University-Purdue University Indianapolis researchers led by microbiologist Gregory G. Anderson of the School of Science examine the role of a protein present in P. aeruginosa, the magnesium transporter MgtE. MgtE plays a crucial role in signaling bacteria when and where to form biofilms, clusters of bacteria that produce "slime" to shield themselves from the CF patient's immune system as well as from antibiotics, thus making the bacteria clusters extremely difficult to attack and kill.

Advertisement


MgtE activity in P. aeruginosa appears to be influenced by the bacterium's chemical surroundings, including the abnormal mucus in CF patients. Specifically, MgtE responds to fluctuations in magnesium levels.

"We know quite a lot about the regulatory signaling that is involved in the bacterium telling itself to form a biofilm, but we haven't had much knowledge about the molecular signals that tell these organisms that it's an appropriate time and place to cluster," said Anderson, corresponding author of the new study. "Specifically, we haven't known what signals bacteria are receiving from the environment -- in this case, the mucus in CF patients' lungs -- to tell them to form biofilms.
Advertisement

"We have now tied MgtE, a protein in the membrane of bacteria, with known biofilm signaling networks. I think this is one of the first times such a link between an external signal and biofilm regulation has been identified. We are adding to the body of knowledge of biofilm formation with the ultimate goal of finding better ways to disrupt that formation, leading to improved treatments for the chronic pneumonia in CF patients."

Infections in cystic fibrosis patients cause breathing difficulties resulting in serious strain on the lungs, cardiovascular system and heart.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Genetics & Stem Cells News

Is Stem Cell Therapy Safe for Relapsing-Remitting Multiple Sclerosis Treatment?
Relapsing-remitting multiple sclerosis has been successfully treated using autologous hematopoietic stem cell therapy.
Genetic Insights Into Androgenetic Alopecia's
Innovative discoveries in male hair loss research uncover uncommon genetic variants tied to it.
Uncovering Genetic Harmony for Safer Hearts
Researchers achieved a significant milestone in uncovering the genetic basis of dilated cardiomyopathy in Dobermanns.
Gene Therapy Breaks Up New Dawn for Beta Thalassemia
Groundbreaking gene therapy for genetic beta thalassemia is now accessible as a treatment to a patient post-FDA approval.
Scientists Uncover Stem Cells in the Thymus for the First Time
Thymic stem cells actively participate in their environment by generating extracellular matrix proteins, essentially forming their own support system.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Development of Biofilms in CF Associated Chronic-pneumonia Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests